+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report

  • PDF Icon

    Report

  • 158 Pages
  • January 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139838

Global High-Density Multiplexed Diagnostic Assays Market to Reach $4.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for High-Density Multiplexed Diagnostic Assays estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2022-2030. Diagnostic Laboratories, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hospitals & Clinics segment is readjusted to a revised 14.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $474 Million, While China is Forecast to Grow at 13.8% CAGR

The High-Density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$474 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$819.1 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Erba Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Gold Standard Diagnostics Corporation
  • Hologic, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for High-Density Multiplexed Diagnostic Assays

What is the estimated value of the Global Market for High-Density Multiplexed Diagnostic Assays?

The Global Market for High-Density Multiplexed Diagnostic Assays was estimated to be valued at $1.6 Billion in 2022.

What is the growth rate of the Global Market for High-Density Multiplexed Diagnostic Assays?

The growth rate of the Global Market for High-Density Multiplexed Diagnostic Assays is 15.0%, with an estimated value of $4.9 Billion by 2030.

What is the forecasted size of the Global Market for High-Density Multiplexed Diagnostic Assays?

The Global Market for High-Density Multiplexed Diagnostic Assays is estimated to be worth $4.9 Billion by 2030.

Who are the key companies in the Global Market for High-Density Multiplexed Diagnostic Assays?

Key companies in the Global Market for High-Density Multiplexed Diagnostic Assays include Abbott Laboratories, Agilent Technologies, Inc., Bio, Rad Laboratories, Inc., Erba Diagnostics, Inc., F. Hoffmann, La Roche AG, Gold Standard Diagnostics Corporation and Luminex Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • High-density Multiplexed Diagnostic Assays - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World High-Density Multiplexed Diagnostic Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for High-Density Multiplexed Diagnostic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 12: USA Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 13: USA 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: Canada Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: Canada 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
JAPAN
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 18: Japan Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: Japan 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
CHINA
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 20: China Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: China Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: China 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
EUROPE
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: Europe Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for High-Density Multiplexed Diagnostic Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
FRANCE
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 29: France Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: France Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: France 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
GERMANY
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Germany Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Germany 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Italy Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Italy 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: UK Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: UK 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: Rest of Europe Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: Rest of Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 44: Asia-Pacific Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Asia-Pacific Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Asia-Pacific 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 47: Rest of World Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of World Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Rest of World 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Erba Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Gold Standard Diagnostics Corporation
  • Hologic, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.